Company Overview
About Inceptive
Inceptive is a Berlin and San Francisco-based biotechnology company founded in 2021 by Jakob Uszkoreit (former senior scientist at Google Brain and co-inventor of the Transformer architecture), Rhiju Das (Stanford RNA biophysicist), and other co-founders. The company is applying deep learning to the problem of RNA design — predicting and engineering synthetic RNA sequences that fold into specific structures and perform specific biological functions, such as encoding therapeutic proteins (mRNA medicines), silencing disease genes (siRNA, antisense), or regulating cellular behavior through aptamers and riboswitches.
Business Model & Competitive Advantage
The company raised a $100M Series A led by Andreessen Horowitz Bio + Health, with additional investors including Lux Capital and GV (Google Ventures). Inceptive's approach combines large-scale experimental data generation (synthesizing and testing hundreds of thousands of RNA sequences) with deep learning models trained on the resulting structure-function datasets, creating an iterative improvement loop. The company's deep learning expertise — drawing directly from the Transformer architecture that underpins modern LLMs — is applied to learning the grammar of RNA sequence-to-structure-to-function relationships.
Competitive Landscape 2025–2026
The therapeutic RNA space has been validated at enormous scale by the success of mRNA COVID vaccines (Moderna, BioNTech) and a growing pipeline of mRNA medicines for rare diseases, cancer, and infectious diseases. However, designing RNA molecules with optimal immunogenicity profiles, stability, and protein expression levels remains an empirical challenge — one that Inceptive's AI platform is built to solve systematically. The company positions RNA as "biological software" that can be rapidly designed and reprogrammed for new therapeutic targets, with AI as the development environment.
Key Differentiators
Emerging Innovator
Inceptive is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Compare Inceptive with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Inceptive? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Inceptive Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Inceptive vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →